---
title: "Post‑Dobbs evidence: What data show about abortion access, mortality, and advocacy"
id: "stat-news-3-opinion-many-post-dobbs-abortion-fears-have-not-come-to-pass-what-does-that"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-3-opinion-many-post-dobbs-abortion-fears-have-not-come-to-pass-what-does-that"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/08/26/dobbs-abortion-predictions-infant-mortality-data-freedom/?utm_campaign=rss"
published_at: "2026-08-26T08:30:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Post‑Dobbs evidence: What data show about abortion access, mortality, and advocacy
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-3-opinion-many-post-dobbs-abortion-fears-have-not-come-to-pass-what-does-that
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/08/26/dobbs-abortion-predictions-infant-mortality-data-freedom/?utm_campaign=rss)
- **Published At:** 2026-08-26T08:30:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The author, a maternal‑fetal medicine physician, reviews early empirical signals more than four years after the Supreme Court decision in **Dobbs v. Jackson**. - One study identified a relative increase of about 5.6% in **infant mortality** in states with heavy limits on abortion access; likely contributors include bans on termination for congenital anomalies and forced continuation of high‑risk pregnancies. - National **maternal mortality** rates have not shown a clear net increase in available analyses, but measurements are complicated by the overlap with the COVID‑19 pandemic and by preexisting state differences; harms to individual patients from bans have been documented. - Contrary to early expectations, overall abortion counts may be stable or rising nationally; legal restrictions are only one of many determinants, and activists, clinicians, telehealth, and medication abortion have preserved access in many areas. - The feared large‑scale migration of OB‑GYNs out of restrictive states has not been borne out at the national level; estimates show minimal net workforce shifts (near zero or 1%–2%), although individual relocations have occurred. - The author cautions against evaluating abortion policy solely by downstream outcomes (a consequentialist approach), arguing that bans are also a deontological violation of autonomy and freedom regardless of measured health effects. - Future changes in mortality or workforce could be delayed rather than absent; reliance on evolving data risks reframing advocacy into statistical debate rather than a rights‑based argument. - The piece emphasizes preserving ethical framing centered on autonomy and freedom while continuing to scrutinize evolving empirical evidence, and notes legal threats to **mifepristone** could still jeopardize preserved access.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/08/26/dobbs-abortion-predictions-infant-mortality-data-freedom/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/08/26/dobbs-abortion-predictions-infant-mortality-data-freedom/?utm_campaign=rss) [research](https://www.statnews.com/topic/research/) [Cancer](https://www.statnews.com/topic/cancer/) [Donald Trump](https://www.statnews.com/topic/donald-trump/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT Events](https://www.statnews.com/events/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds-nominate/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) Opinion[First Opinion](https://www.statnews.com/category/first-opinion/) # Many post-Dobbs abortion fears have not come to pass. What does that mean for advocates? ## Arguments about abortion rights should be rooted in freedoms, not data * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/08/26/dobbs-abortion-predictions-infant-mortality-data-freedom/?utm_campaign=rss) ![](https://www.statnews.com/wp-content/uploads/2026/08/AP151785795154-645x645.jpg) Eric Gay/AP By David N. Hackney Aug. 26, 2026 Hackney is professor of reproductive biology at Case Western Reserve University and division chief of maternal fetal medicine. The biggest surprise over a medical career is how often you find yourself surprised. Theories perfect on paper flounder in the real world. Proposed treatments that fit our understanding of disease will unexpectedly fail human trials. Cells, organs, human bodies, and health care systems are complicated, so as a doctor, you train yourself to be humble and wait for data that might not arrive for years. But we still make predictions, and often find ourselves startled by the outcome. Like many people, I assumed several things would happen after Roe v. Wade was overturned: Abortion rates would fall, infant and maternal deaths would both worsen, and doctors practicing in states where abortion become heavily restricted would flee to other parts of the country. Advertisement These were all reasonable presumptions at that time but would also require years of data to evaluate. Now, more than four years since the Supreme Court decision in Dobbs v. Jackson Women’s Health Organization, we have an emerging picture, and many outcomes are surprising. But the fact that many of the worst predictions have not come to pass does not mean anyone should change their views on abortion restrictions, provided our guiding principles are autonomy and freedom. So, where do health measures currently stand after Dobbs? Let’s first unpack the prediction that proved correct: Infant mortality has increased in states where abortion access is heavily restricted — a relative increase of 5.6%, according to [one study](https://jamanetwork.com/journals/jama/fullarticle/2830298). Advertisement Related Story ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_278075961-768x432.jpeg) ### [The new geography of abortion care](https://www.statnews.com/2026/08/11/abortion-post-dobbs-clinic-hotline-advice/) There are two likely reasons for this. First, numerous states banned abortion for any congenital or genetic anomalies, even those inconsistent with survival — a cruelty to which we should never inure. More babies are being born with these conditions, and thus more babies are dying. The second is that patients with high-risk conditions are also being forced to continue — often resulting in adverse outcomes for their pregnancies. So, if infant mortality has risen, has maternal mortality worsened also? Surprisingly, a net increase [has not been clearly identified](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2847291#google_vignette). This carries many caveats, including the fact that bans coincided with the tail of the Covid-19 pandemic. As the virus alone drove mortality, attempts to measure overlapping effects are complicated. Also, a stable overall mortality can mask worse outcomes in restrictive states or within minoritized groups. Mortality rates are worse in states that have abortion bans, though these differences predated Dobbs and [on average have been stable after](https://obgyn.onlinelibrary.wiley.com/doi/full/10.1002/pmf2.70128). Even if the total national rates have not changed, we know that, since Dobbs, individual patients have died as direct results of bans. For these patients, and their loves ones, the epidemiology is forever meaningless. America’s maternal and pregnancy-associated mortality rates are also the worst among high income countries, so only improvement should be acceptable; an unchanged rate is a tragedy rather than celebration of stability. Another eminently logical assumption at the time of Dobbs was that the number of abortions would decrease. But abortions may [instead be increasing](https://www.kff.org/womens-health-policy/abortion-trends-before-and-after-dobbs/). Why? First, abortion frequency is a result of multiple drivers of which laws are but one piece alongside economics, contraception, societal changes, and many others. The adage that laws don’t stop abortions proves valid again. Related Story ![](https://www.statnews.com/wp-content/uploads/2025/09/AP25241487853123-768x432.jpg) ### [Celebrating mifepristone, a hero in modern abortion access, on its 25th anniversary in the U.S.](https://www.statnews.com/2025/09/28/mifepristone-abortion-pill-fda-approval-25th-anniversary/) Additionally _,_ the historic moment was met by an army of activists, advocates, and health care workers laboring to preserve access, often taking advantage of telehealth and even putting themselves at legal risk. Advertisement The national averages, however, risk masking the legions in restrictive states still not accessing care. Additionally, much of the preserved access depends upon mifepristone, which faces legal peril. And what of the fourth prediction, that doctors would leave restrictive states? Collectively across the country, recent estimates have identified net changes [of zero](https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2833030?utm_campaign=articlePDF&utm_medium=articlePDFlink&utm_source=articlePDF&utm_content=jamahealthforum.2026.1184) or only 1%-2% for OB-GYNs moving from restrictive to unrestrictive locations. Though individual physicians have relocated in response to changing laws, the nationwide exodus that was feared has not occurred. In science, results that are counterintuitive are also often fascinating. As a doctor, my habit is to read new studies focused on their methodologies: their pitfalls, caveats, and potential for false negatives. But to focus too narrowly upon the statistics, data, and results will also risk missing the point. Broadly, our views here can be consequentialist or deontological; is something good or bad because it yields good or bad outcomes, or bad on a basis of our values alone? In medicine, our nature is to err toward consequences. Measurable outcomes are how we select medications or procedures, how we evaluate clinical trials. We can slip into viewing abortion bans through the same lens, judging their impacts on mortality rates or workplace demographics. But we can’t lose sight of the foundational ethical assault. Bans need not increase or decrease public health measures for opposition, but are opposed as misogynistic violations of autonomy. A consequentialist viewpoint risks dependence on outcomes, which in medicine are dastardly unpredictable. Opponents of abortion, for example, also adopt outcome-centered arguments to their peril, claiming that abortion increases risks of breast cancer and mental illness, which are, in rigorous studies, invalid. As a result, they emerge on the wrong side of oncologic and psychiatric debates. In the years to come, our data on the consequences of abortion bans may well further shift. In particular, I suspect that changes in mortality and our workforce may just be delayed rather than circumvented. But contingency is best avoided. When arguments are based on consequences, we then argue about data when we should be fighting for freedoms. Advertisement _David N. Hackney, M.D., M.S., is professor of reproductive biology at Case Western Reserve University and division chief of maternal fetal medicine. His new book is “[Impossible Choices: A Physician’s Guidance on High-Risk Pregnancy in a World Without Roe](https://mitpress.mit.edu/9780262054706/impossible-choices/),” out now from The MIT Press._ * * * ###### Letter to the editor Have an opinion on this essay? [Submit a letter to the editor](https://www.statnews.com/submit-a-letter-to-the-editor/?subject=Many%20post-Dobbs%20scenarios%20have%20not%20come%20to%20pass.%20What%20does%20that%20mean%20for%20advocates?). [abortion](https://www.statnews.com/topic/abortion/), [advocacy](https://www.statnews.com/topic/advocacy/), [legal](https://www.statnews.com/topic/legal/), [public health](https://www.statnews.com/topic/public-health/), [reproductive health](https://www.statnews.com/topic/reproductive-health/), [states](https://www.statnews.com/topic/states/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. David N. Hackney ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/First-Opinion-Logo-Black-640x319.png) ### Newsletter The smartest thinkers in life sciences on what's happening — and what's to come Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/08/20260729_STATRuralHospitalMDI_0093-80x80.jpg) [How Trump’s cuts are reshaping America’s health system](https://www.statnews.com/2026/08/25/rural-hospitals-response-medicaid-cuts-part-1-unraveled-series/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/08/GettyImages-2270934863-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Comments on OMB research rule mysteriously removed from federal website](https://www.statnews.com/2026/08/25/russell-vought-omb-funding-comments-daughter-benefited-nih-research/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_451619906_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Sword Health to acquire Headspace, according to filing](https://www.statnews.com/2026/08/25/sword-health-to-acquire-headspace-per-regulatory-filing/) 4. ![](https://www.statnews.com/wp-content/uploads/2023/02/AdobeStock_525959126_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Turkish antitrust authorities probe Teva for allegedly gaming the patent system, disparaging rival drugs](https://www.statnews.com/pharmalot/2026/08/25/turkish-authorities-probe-teva-gaming-patent-system-disparaging-rivals/) 5. ![](https://www.statnews.com/wp-content/uploads/2024/05/s3___bgmp-arc_arc-feeds_generic-photos_to-arc_Wiggs-_Bedford_2-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA approves Ultragenyx gene therapy](https://www.statnews.com/2026/08/20/biotech-news-fda-approves-utlragenyx-gene-therapy/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2025/08/VCFirms2025_LeftRailUnit-328x426.png) 2025 Edition: Ranking Biotech’s Top Venture Capital Firms ](https://reports.statnews.com/products/biotech-top-venture-capital-firms-2025) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/924_Samsung_VirtualEvent_Wordpress_FeaturedImage-80x80.jpg) Biosimilars: Have We Reached an Inflection Point? Virtual Sep 24 ](https://www.statnews.com/event/biosimilars-what-is-next-virtual-event-sept-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/01/Flagship2026_Wordpress_CalendarImageRegGoLive-1-80x80.jpg) 2026 STAT Summit Boston, MA Oct 14 ](https://www.statnews.com/event/2026-stat-summit/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/2026_DD_OfficeHours_VirtualEvent_Wordpress_CalendarImage-80x80.jpg) Office Hours with Isabella Cueto and Lev Facher Virtual Jul 29 ](https://www.statnews.com/event/deadliest-drug-series-office-hours-ama-july-2026/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2020/02/AdobeStock_284333299-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial](https://www.statnews.com/2026/08/19/mrna-cancer-vaccine-trial-melanoma-merck-moderna/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/08/image-15-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Inside Moderna and Merck’s cancer vaccine triumph](https://www.statnews.com/2026/08/24/inside-moderna-and-merck-cancer-vaccine-triumph/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/08/AP26111614763455-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [HHS document offers new clues to Kennedy’s vaccine plans](https://www.statnews.com/2026/08/21/rfi-reveals-possible-kennedy-strategy-vaccine-policy-changes/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/08/LongLab_Immunofluorescence-of-the-biosynthetic-enzyme-for-exercise-inducible-Lac-Phe-Cndp2-green-and-nuclei-DAPI-blue-in-mouse-gut-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A pill that mimics exercise? Early results on drug designed to maintain both weight loss and muscle mass](https://www.statnews.com/2026/08/18/enveda-pill-mimics-exercise-phase-one-trial-leptin-weight-loss-maintenance/) 5. ![](https://www.statnews.com/wp-content/uploads/2022/06/AdamsTake_Illustration_MollyFerguson_061322-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection](htt
## Related Clinical Research

- [Keto Diet Shows Superior Metabolic Benefits Over Mediterranean and Low-Fat Diets](https://medichelpline.com/clinical-feed/medical-news-today-1-keto-diet-may-have-metabolic-advantages-over-mediterranean-low-fat-diets.md)
- [Coffee consumption associated with lower visceral fat, higher muscle mass, and hormonal differences](https://medichelpline.com/clinical-feed/medical-news-today-0-coffee-drinking-linked-to-less-abdominal-fat-more-muscle-better-hormone-balance.md)
- [Cancer screening and long-term care facilities: gaps highlighted by a missed breast cancer diagnos](https://medichelpline.com/clinical-feed/stat-news-3-opinion-cancer-screening-guidelines-need-to-address-long-term-care-facilities.md)
- [Why splitting the MMR vaccine could raise public health risks](https://medichelpline.com/clinical-feed/stat-news-2-how-we-know-that-splitting-up-the-mmr-vaccine-could-be-dangerous.md)
- [Cardiac-targeted delivery strategies for advanced therapies in heart disease](https://medichelpline.com/clinical-feed/pubmed-42284133.md) (DOI: 10.1093/eurheartj/ehag432)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.